Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05621837

Quantifying Systemic Immunosuppression to Personalize Cancer Therapy

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

View on ClinicalTrials.gov

Summary

The Serpentine (Stratify cancER PatiENTs by ImmuNosupprEssion) project, represents the most consistent effort so far attempted to translate MDSC into clinical practise by producing an off-the-shelf compliant assay for quantifying these cells in peripheral blood.

Key Details

Gender

All

Age Range

18 Years - 90 Years

Study Type

OBSERVATIONAL

Enrollment

1000

Start Date

2022-03-10

Completion Date

2026-12-31

Last Updated

2025-05-02

Healthy Volunteers

Yes

Interventions

OTHER

MDSC quantification

Blood sample will be collected at baseline and during therapy, and, optionally, in case of disease progression (PD).

Locations (1)

Fondazione IRCCS Istituto Nazionale dei Tumori

Milan, Italy